Key stats
About Fidelity MSCI Health Care Index ETF
Expense ratio
0.08%
Home page
Inception date
Oct 21, 2013
FHLC casts a wide net across the entire health care market in the US, capturing over 300 large-, mid- and small-cap companies and spanning more than 10 subsectors. This diversification gives the vanilla fund less exposure to the big pharma companies that dominate the market, and more exposure to sectors like drug retailers and insurance. Prior to December 1, 2020, the fund tracked the MSCI USA IMI Health Care Index, an uncapped version of the present index. To meet diversification requirements, FHLC now uses a 25/50 capping methodology. Notably, instead of replicating the underlying index, the fund uses a representative sampling strategy. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.67%
Health Technology77.97%
Health Services16.21%
Distribution Services2.68%
Retail Trade0.95%
Technology Services0.85%
Commercial Services0.41%
Process Industries0.30%
Finance0.27%
Electronic Technology0.02%
Bonds, Cash & Other0.33%
Mutual fund0.30%
Cash0.03%
Miscellaneous0.00%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history